Abstract: In this study, the results first showed that CYP1A1 and CYP1A2 variants were associated with stroke risk. Larger and well-designed studies are needed to confirm the results.
Introduction
Stroke is a leading cause of mortality and long-term disability worldwide, with a particularly high burden in China, where over 2 million new cases are reported annually. While lifestyle factors such as hypertension, diabetes, and smoking are established risk factors, they do not fully account for individual susceptibility. Recent research has turned toward "missing heritability," investigating genetic predispositions to vascular events.
This study focuses on the Cytochrome P450 (CYP) enzyme family, specifically CYP1A1 and CYP1A2. These enzymes are critical for metabolizing various endogenous and exogenous compounds, including fatty acids and drugs, and are involved in oxidative stress pathways. Polymorphisms in these genes may alter enzyme activity, thereby influencing an individual's risk of stroke.
Methods
A case-control study was conducted involving 957 participants from Shaanxi Province, China. The cohort consisted of 477 stroke patients (confirmed via CT or MRI) and 480 healthy controls. Four Single Nucleotide Polymorphisms (SNPs)—rs1048943, rs4646422, rs762551, and rs2470890—were selected based on the 1000 Genomes Project data, ensuring the variants studied were common enough to be statistically relevant.
Genotyping was performed using the Agena MassARRAY Assay. Statistical analyses, including chi-square tests and logistic regression (adjusted for age and gender), were employed to evaluate the association between these SNPs and stroke risk. Additionally, Linkage Disequilibrium (LD) and haplotype analyses were conducted using Haploview software to identify co-inherited genetic variants.
Results
Primary Genetic Associations
The most significant finding centered on the rs762551 variant in the CYP1A2 gene. The study identified that the C allele of this SNP is associated with a significantly lower risk of stroke compared to the A allele (OR = 0.82, 95% CI: 0.68–0.99).
Demographic and Comorbidity Specificity
The association between genetic variants and stroke risk varied significantly across different demographic groups and clinical subgroups:
- Age and Gender: The protective effect of the rs762551 variant was most pronounced in males and individuals aged 64 and younger. In the younger subgroup (≤64 years), the recessive model for rs762551 showed a marked reduction in risk (OR = 0.56). Similarly, in males, the codominant model revealed a significant protective effect (OR = 0.56).
- Hypertension: In patients with hypertension, the rs2470890 C allele was linked to an increased risk of stroke (adjusted OR = 1.68).
- Coronary Heart Disease (CHD): For patients with CHD, the rs4646422 C allele was associated with a 1.54-fold increase in stroke likelihood.
Haplotype Synergy
Haplotype analysis provided deeper insights than single SNP evaluations. Specifically, the "AT" haplotype (comprising variants of rs762551 and rs2470890) was associated with decreased susceptibility to stroke, particularly among hypertensive patients, suggesting a synergistic effect between these genetic loci.
Discussion
This study provides evidence that CYP1A1 and CYP1A2 polymorphisms are significant markers for stroke risk in the Chinese population. The findings highlight the importance of considering demographic factors like age and gender, as well as comorbidities like hypertension, when assessing genetic risk.
However, several limitations must be acknowledged. The sample size of under 1,000 participants may limit the power to detect rare genetic interactions. Furthermore, the study population was geographically restricted to Shaanxi Province, and lifestyle factors such as smoking and BMI were not fully accounted for. Future research should utilize larger, multi-ethnic cohorts and functional molecular studies to elucidate the biological mechanisms by which these variants influence stroke pathogenesis.
Summary updated